Pediatric Cancer Therapeutics Development / Pediatric Oncology (PDF)
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
This book provides a comprehensive overview of the scientific, medical, regulatory, and economic considerations associated with the discovery, development, and delivery of novel therapeutics for children with cancer. Co-authored by a diverse team from academic, government, and industry backgrounds, the book describes the steps in the process from the identification of a promising therapeutic target to the evaluation of drug candidates in the various phases of clinical testing and regulatory review. Throughout, special emphasis is placed on the unique biology of pediatric malignancies and the medical and social needs of children and their families. In providing a firm grounding in the drug development process, the book will be of value to all with an interest in how medicines currently used to treat pediatric cancer were made available. This includes trainees as well as established practitioners and others participating in translational and clinical research in the academic setting.
Gregory H. Reaman, M.D. joined the Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration as the Associate Director of the Office of Oncology Drug Products in 2011. In 2017, he bacame the Associate Director for Pediatric Oncology in the FDA's Oncology Center of Excellence. He is the Founding and Immediate Past Chair of the Children's Oncology Group (COG) having served in this capacity from 2000 through 2010. The COG is comprised of over 200 member institutions, dedicated to clinical, translational, and epidemiology research in childhood cancer. He is a Professor of Pediatrics at The George Washington University School of Medicine and Health Sciences and a member of the Division of
Franklin O. Smith, III, M.D., FAAP, FACP, is Senior Vice President at Medpace and is Professor of Medicine and Pediatrics at the University of Cincinnati College of Medicine. He graduated from the University of South Carolina School of Medicine and completed postdoctoral training in pediatrics at the University of Florida and fellowship training in pediatric hematology/oncology at the University of Washington and the Fred Hutchinson Cancer Research Center. Prior to joining Medpace, Dr. Smith was the Clinical Director at the University of Cincinnati Cancer Institute. Previously, he was the Director, Division of Hematology/Oncology at Cincinnati Children's Hospital Medical Center and Vice-Chair of the Children's Oncology Group. He has authored more than 180 medical and scientific articles, book chapters and books. Dr. Smith is active with various national and international committees and societies in the field of research and clinical care. He currently serves as President of the Board of Managers for FACT Consulting Services and faculty for the ASCO/AACR Clinical Cancer Research Workshop. Dr. Smith has also served on standing and ad hoc committees for the FDA and NIH.
- 2022, 1st ed. 2022, 181 Seiten, Englisch
- Herausgegeben: Jorge DiMartino, Gregory H. Reaman, Franklin O. Smith
- Verlag: Springer Nature Switzerland
- ISBN-10: 3031063570
- ISBN-13: 9783031063572
- Erscheinungsdatum: 18.11.2022
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
- Dateiformat: PDF
- Größe: 8.87 MB
- Ohne Kopierschutz
- Vorlesefunktion
Schreiben Sie einen Kommentar zu "Pediatric Cancer Therapeutics Development / Pediatric Oncology".
Kommentar verfassen